Viking Therapeutics' dual-action contender could add to pharmacy benefits cost pressure.

Bernie Sanders' committee voted 20-1 to investigate the hospital company and 16-4 for the subpoena.

Rep. Nick Langworthy asked about duty of care at a committee hearing featuring three top PBM executives.

A new report also reveals how much sicker platinum plan enrollees really are.

Employers may be doing better than other payers at holding costs down.

One provision would keep PBMs from steering enrollees toward their mail-order pharmacies.

Fewer told Milliman they rate the offerings as important to recruiting and retaining employees.

For benefits brokers and benefits managers, one revelation may be the lack of a system recovery tracker.